Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03432650 · ClinicalTrials.gov registry record · Phase 3
Evaluation of Anterior Quadratus Lumborum Block for Postoperative Analgesia in Hip Arthroscopy
A Phase 3 study, sponsored by Hospital for Special Surgery, New York.
- Completed
- Registry status
- Phase 3
- Development phase
- 96
- Enrollment target
NCT03432650 is a Phase 3 study that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 96 participants.
The verdict
NCT03432650, a Phase 3 study, has completed, sponsored by Hospital for Special Surgery, New York.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 96 participants
- Enrollment target
Study Summary
Hip arthroscopy is performed frequently and the postoperative course often involves moderate to severe pain. There remains no definitive perioperative pain regimen that has been proven to be effective and safe for this ambulatory procedure. Some institutions perform peripheral nerve blocks either preoperatively or postoperatively as a rescue block. All of these PNBs lead to quadriceps weakness which may impede earlier mobilization and physical therapy. While some case reports exist, there have not been any studies evaluating the QLB for hip arthroscopy patients. As previously mentioned, the technique is easy to perform, well-tolerated by patients, and avoids side effects such as hypotension, urinary retention, or the quadriceps weakness associated with lumbar plexus blockade.
Interventions
- DEVICE Ultrasound
- DRUG Bupivacaine + dexamethasone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2018-06-01 |
| Est. Completion | 2021-09-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03432650
The ClinicalTrials.gov registry entry for NCT03432650 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hospital for Special Surgery, New York, which has 194 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ultrasound is the first listed.
NCT03432650 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03432650 about?
NCT03432650 is a clinical study titled "Evaluation of Anterior Quadratus Lumborum Block for Postoperative Analgesia in Hip Arthroscopy". Hip arthroscopy is performed frequently and the postoperative course often involves moderate to severe pain. There remains no definitive perioperative pain regimen that has been proven to be effective and safe for this ambulatory procedure. Some institutions perform peripheral nerve blocks either pr...
What is the current status of trial NCT03432650?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 96 participants. The study started on 2018-06-01. Estimated completion is 2021-09-09.
What interventions are being tested in trial NCT03432650?
The interventions under investigation include: Ultrasound (DEVICE), Bupivacaine + dexamethasone (DRUG).
Who is sponsoring clinical trial NCT03432650?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.